Share Name Share Symbol Market Type Share ISIN Share Description
Empresaria Group LSE:EMR London Ordinary Share GB00B0358N07 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 76.50p 75.00p 78.00p 76.50p 76.50p 76.50p 0 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 357.1 8.1 8.0 9.6 37.26

Empresaria Share Discussion Threads

Showing 1226 to 1250 of 1250 messages
Chat Pages: 50  49  48  47  46  45  44  43  42  41  40  39  Older
DateSubjectAuthorDiscuss
03/9/2018
09:32
hTTps://www.piworld.co.uk/2018/08/22/empresaria-group-emr-h1-results-august-2018/
davebowler
29/8/2018
14:19
So they haven't changed their view from July where they said 100p. This current 100p is dependent on forecasts into 2019. Interestingly, they had said a PER of 11.7 earlier last year but I think at that time there were no market cautions. I think they are a fairly strong quality company and that the price will come back nicely once they start to show improvements in debt and cashflow.
merrimac
29/8/2018
13:38
Is new research on the Emr website. Click through Analysts, leads you to a link to Allenby research. No changes to forecast 12.6p fully diluted and target price 100p. A long way from 150p+ last year......
graham1ty
23/8/2018
10:10
Did you see their update? Doesn't seem revised just market updated...there were no surprises.....seems like the negative view is departing but still not many shares available.....
merrimac
23/8/2018
09:04
Are there any revised forecasts ?
graham1ty
22/8/2018
07:33
Empresaria Group (EMR) H1 results August 2018 - video Https://www.piworld.co.uk/2018/08/22/empresaria-group-emr-h1-results-august-2018/ Empresaria Group CEO Spencer Wreford and Group Finance Director Tim Anderson present highlights of the Group’s interim results for the 6 months ended 30th June 2018. Spencer Wreford (CEO) Overview – 00:21 Tim Anderson (Group FD) Financial highlights – 05:35 Spencer Wreford (CEO) Outlook – 07:39
tomps2
22/8/2018
07:29
To add...it is worth watching the link to the CEO interview...tbh, that is where I formed my opinion.
merrimac
22/8/2018
07:20
Boring, solid, and honest. Like the way they have presented the results.
merrimac
10/8/2018
06:27
So if HVN have been offered 9.1x EV/EBITDA per share, this would indicate that EMR's are price is exceptionally undervalued - reported EV/EBITDA is around 4.2x, my calculation gives less than that.
merrimac
09/8/2018
11:03
What is the HVN effect? Updated, yes of course, Harvey Nash! Duh..
merrimac
09/8/2018
10:47
HVN effect?
davebowler
25/7/2018
15:51
Maybe liontrust fully exited ?
daneswooddynamo
25/7/2018
15:46
Now there are a few nice wee trades
merrimac
25/7/2018
10:05
Definitely not a stock for anyone to jump in for a penny or two. A longer term hold with a careful eye on management quality. Next key date is August 22nd and they had better do a good job at their reporting.
merrimac
25/7/2018
09:25
Anyone who bought on the “leak” yesterday at 76p or 77p, is scrabbling to get out and take a couple of pennies
graham1ty
25/7/2018
08:21
I agree on debt - we need to see that coming down and some indication on that would have been good. When you look at the enterprise value with debt it is hard to get to close to £1.50 at the moment given the lack of seeming growth. You would have thought that the € and $ rates would be really helping so I think that in fact excluding currency movements the performance is not that great. The new CEO needs to pull it out in the finals and the outlook statement at that time to get us moving north of £1
harrogate
25/7/2018
08:00
I am guessing that the leadership is quite "technical" and not so inspirational. Based on my watching of the MELLO, they seemed sound but nothing to inspire, hence may not be thinking of the investor's concerns, nor, marketing their achievements. Also, when people diversify too much, while they reduce risk, they also gravitate to the mean - an average company and as you mention, there may always be an excuse? The middle east is so small and with so many issues I hope they will not expand. But they did flag things were getting sorted out there/here.
merrimac
25/7/2018
07:52
Today’s RNS suggests they had flagged Japan as a problem. Yes, they mention the regulatory change coming. However, that is in a sentence that starts “particularly strong performance”. So, I did not read that as a warning in March. It is all very well having a diversified strategy when you can say this spreads yr risk. The flip side is that there are multiple areas that can go wrong. So Pharma Strategies in 2016, Germany and Dubai in 2017, now Japan in 2018......I hope this does not turn into a company with constant excuses..... Yes, pity they did not mention debt. At the MELLO South there was a very good slide about cash generation. EMR has always thrown off cash, and the debt could be repaid very quickly. However, as it is a worry in a few people’s minds, they could have made a comment on period end debt. Allenby have raised their 2019 forecast from 12.9p to 13.1p on the back of the Solimano acquisition. We will see if Mr Market agrees that they are very cheap. Allenby say they have not factored in recovery in Germany and Middle East, and hint at lots of upside if those recover. But they would say that wouldn’t they.
graham1ty
25/7/2018
07:50
I reckon it should sit around 150p but due to its small nature and volatility may trade at a discount - so 120p would be ok until they have a more consistent picture or brighter outlook stated.
merrimac
25/7/2018
07:41
Yes, comment on Japan in Mar 14 results: RNS 6287H Under the Asia Pacific section. "..particularly strong performances from Skillhouse in Japan......where the positive economic conditions.....and new legislation takes effect in 2018 which limits the time workers can be on temporary or outsourced contracts..."
merrimac
25/7/2018
07:36
Agreed - but you would hope that making nearly 12p this year should stop the share price going lower and if the new CEO can get the quite large German business back in shape then there could be a fair EPS increase in 2019 which is currently not in the forecast. Solid but hard to see what gets us to where we were - hard to see now why I didn't sell at £1.40!!
harrogate
25/7/2018
07:35
The middle east is no real worry as they are a smaller contributor (Saudi issues) according to my calculations (may have bad debt issues there too). Yes, no recovery noted in Germany. Agree with you, the Japan comment was news to me. I will look at my info to see if there are comments on Japan....something to do with temps like it was in Germany? Would have hoped for more of a comment on debt but I daresay this will come later in August. Yes, dull.
merrimac
25/7/2018
07:26
The RNS is reassuring, but not much more. No nasty surprises, but no recovery in Germany and Middle East. And, had they mentioned regulatory change in Japan before ? Have loooked at Finals and the Nov 2017 trading statement, and neither mention Japan. Net fee income flat is disappointing. I suppose the reassurance on the forecasts draws a line under last year’s problems.........but it is pretty dull
graham1ty
25/7/2018
07:06
Good update, no nasties and more earnings to come next year. ... did someone know yesterday then?
funkmasterp12
24/7/2018
18:34
Update is due tomorrow
merrimac
Chat Pages: 50  49  48  47  46  45  44  43  42  41  40  39  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V: D:20181016 18:13:41